Characteristics of cancer survivors and controls with prevalent diabetes among the pooled subjects from the 2007–2011 Korea National Health and Nutrition Examination Survey.

a<p>The total number of subjects among these categories does not equal 2,660 due to missing data.</p><p>Characteristics of cancer survivors and controls with prevalent diabetes among the pooled subjects from the 2007–2011 Korea National Health and Nutrition Examination Survey.</p

Prevalence of: (A) diabetes treatment; and (B) adequate glycemic control, among the cancer survivor and control groups with prevalent diabetes, according to diabetes duration.

<p>Model 1 was adjusted for age and sex; Model 2 was additionally adjusted for education and BMI. We adjusted for multiple tests by applying the Bonferroni method. ^a<i>p</i>-value<0.05 when compared with cancer survivors. ^b<i>p</i>-value<0.05 when compared with non-cancer non-chronic disease controls. ^c<i>p</i>-value<0.15 when compared with cancer survivors. ^d<i>p</i>-value<0.15 when compared with non-cancer non-chronic disease controls.</p

Factors associated with complete liver cancer screening (by both ultrasonography and serum alpha-fetoprotein testing) and incomplete screening compared to never-screening by polychotomous logistic regression.

<p>aOR: adjusted Odds Ratio, CI: Confidence Interval.</p>a<p>Only variables with p-value<0.1 in the univariate analysis were included in multivariate analysis.</p>b<p>Both ultrasonography and serum alpha-fetoprotein test.</p>c<p>Either ultrasonography or serum alpha-fetoprotein test.</p

Basic characteristics of the study sample.

a<p>Either ultrasonography or serum alpha-fetoprotein test.</p

Flowchart of the study population.

<p>KNHANES IV (fourth Korean National Health and Nutrition Examination Surveys), HBsAg (hepatitis B surface antigen), and HCV(hepatitis C virus).</p

Factors associated with regular (in previous 6 months) and irregular liver cancer screening compared to never-screening by polychotomous logistic regression.

<p>aOR: adjusted Odds Ratio, CI: Confidence Interval.</p>a<p>Only variables with p-value<0.1 in the univariate analysis were included in multivariate analysis.</p>b<p>Those who got liver cancer screening within previous 6 months.</p>c<p>Those who got liver cancer screening but the interval was longer than 6 months.</p

Flow chart representing the selection procedure based on the NHIS cohort data set from 2002–2013.

<p>^a Surgery codes: R4122, R4160, R4165, R4166, R4170, R4181, R4182, R4183, R4331, R4332, R4341, R4342, R4345, R4421, R4430, and R4435. ^b Gonadotropin-releasing hormone agonist codes and danazol codes: 182602BIJ, 182604BIJ, 244902BIJ, 167202BIJ, 167201BIJ, 198501CSI, 140301ACH, and 140302ACH. Abbreviations: EMS, Endometriosis; NHIS, National Health Insurance Service; GnRH, Gonadotropin-releasing hormone.</p

Lifetime (a) and regular (b) liver cancer screening rates according to screening method in high risk population of liver cancer by age.

<p>Lifetime liver cancer screening rate, regular liver cancer screening rate, and complete liver cancer screening in the entire study sample were 39.6%, 12.3%, and 14.6%, respectively.</p

Characteristics of patients in the endometriosis group and the control group, 2002–2013.

<p>^a First diagnosis of EMS was made in the year noted.</p><p>^b Mean age groups per 5 years in 2013. 1; 0–4 years, 2; 5–9 years,……., 17; 80–84 years, 18; 85 years+.</p><p>^c The mean age was calculated from the mean age groups per 5 years.</p><p>^d Mean socioeconomic status groups in 2013. 1; upper 0–9%, 2; upper 10–14%,……., 9; upper 90–94%, 10; upper 95%+.</p><p>^e Fisher’s exact test</p><p>Data are presented as numbers or means ± standard deviations</p><p>Characteristics of patients in the endometriosis group and the control group, 2002–2013.</p

Multivariate logistic regression analysis of endometriosis and nickel allergy.

<p>^a Covariates: Age group per 5 years, socioeconomic status group (decile), nickel allergy.</p><p>CI, Confidence interval; OR, Odds ratio</p><p>Multivariate logistic regression analysis of endometriosis and nickel allergy.</p